Global Clinical Decision Support System Market Share Is Likely to Grow at A CAGR Value of Around 11.9% By 2028

29-Jul-2022 | Facts and Factors

According to Facts and Factors, the Global Clinical Decision Support System Market size was worth USD 1,382.4 million in 2021 and is estimated to grow to USD 2,714.1 million by 2028, with a compound annual growth rate (CAGR) of approximately 11.9% over the forecast period. The report analyzes the Clinical Decision Support System Market, the drivers, restraints/challenges, and their effect on the demands during the projection period. The study also looks at new potential in the market for healthcare decision support systems.

The Clinical decision support system is intelligent, examines historical data and treatment trends, and makes wise judgments to enhance patient health. A key benefit of a healthcare decision support system is that it gives clinicians, workers, and patients expertise and person-specific information. Therefore, systems with cutting-edge algorithms, interactive user interfaces, and service-oriented architectures are currently needed on a worldwide scale to deal with the fast-rising frequency of chronic diseases and the escalating patient population.

Browse the full “Clinical Decision Support System Market Size, Share, Growth Analysis Report By Deployment Type (On-Premise, Web-Based, and Cloud-Based), By Model (Knowledge-Based Model and Non-Knowledge Based Model), By Product Type (Standalone HDSS Solution and Integrated HDSS Solution), By Offering (Hardware, Software, and Services), By Application (Drug-Drug Interactions, Drug Dosing Support, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines, and Others), and By Region-Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2022 – 2028" report at https://www.fnfresearch.com/clinical-decision-support-system-market

The demand for sophisticated software solutions to effectively manage the rapidly expanding patient population around the world is anticipated to drive the growth of the global market for healthcare decision support systems during the anticipated time frame. Additionally, it is widely anticipated that the ability of software technology to forecast patient situations will accelerate the use of healthcare decision support systems in the near future.

Data management, analytics, and storage platforms are being improved and optimized as a result of the quick developments in biotechnology and bioinformatics. The market is expected to experience a significant number of innovations as a result of R&D programs supported by significant corporate investments. In addition, the incorporation of interoperability and cloud computing platforms into various systems would further encourage efficient operation, and seamless data flow, ultimately accelerating the uptake of healthcare decision support systems.

Segmental Overview

Hardware, software, and services comprise the market's three main segments. The industry is divided into Standalone HDSS solutions and Integrated HDSS solutions based on the kind of product. The Clinical Decision Support System Market is divided into the Knowledge-Based Model and Non-Knowledge Based Model based on model. The market is segmented into On-Premise, Web-Based, and Cloud-Based based on the type of deployment. Clinical Guidelines, Drug Allergy Alerts, Drug-Drug Interactions, Drug Dosing Support, Clinical Reminders, and Others are the different application categories in the industry.

Regional Overview

In 2021, North America held a revenue share of more than 45.0%, dominating the world market for healthcare decision support systems. This can be linked to the growing need in the medical industry for healthcare I.T. solutions. The market expansion in this region is also fuelled by quick technology development and the rising relevance of offering high-quality healthcare services.

Over the projected period, the region with the quickest growth is expected to be the Asia Pacific. This is due to countries like Australia, China, India, and Japan making larger investments in the healthcare industry. Furthermore, the Asia Pacific market is exhibiting significant potential due to rising R&D spending by the governments of important economies to boost the penetration of information technology in the medical industry. In addition, the growing elderly population is probably one of the major drivers of the Asia Pacific market.

Report Scope

Competitive Landscape

Key players functioning in the Clinical Decision Support System Market include Cerner Corporation (U.S.), Change Healthcare (U.S.), Epic Systems (U.S.), MEDITECH (U.S.), Philips Healthcare (Netherlands), Elsevier B.V. (U.K.), IBM Watson Health (U.S.), Wolters Kluwer N.V. (Netherlands), Zynx Health (U.S.), Allscripts Healthcare LLC (U.S.), athenahealth (U.S.), Visual DX (U.S.), Stanson Health (U.S.), First Databank, Inc (U.S.),  NextGen Healthcare (U.S.), Siemens Healthineers (U.S.), EBSCO Health (U.S.), G.E. Healthcare (U.S.), eClinicalWorks (U.S.), RAMPMedical (Germany), The Medical Algorithms Company Limited (U.K.), Hera-MI (France), CureMD Healthcare (U.S.), CareCloud, Inc (U.S.), and Strata Decision Technology (U.S.).

Recent developments:

• In July 2018, Elsevier and RELX Group reached a strategic partnership agreement with the goal of creating and commercializing STATdx, an online radiology diagnostic decision assistance tool.
• In order to build and develop the Integrated Blood Management System, Mayo Clinic and National Decision Support Company (NDSC) reached a strategic cooperation agreement in August 2018. (IBMS). The new launch will increase the product portfolio of NSDC's EHR-enabled clinical decision support system and Mayo Clinic's clinical expertise.
• F. Hoffmann-La Roche Ltd. introduced two new software programmes in September 2018 to their line of clinical decision support systems. Finding pertinent information on a specific disease condition or drug phase on clinical trial and medical publishing databases is the goal of NAVIFY Clinical Trial Match and NAVIFY Publication Search.

The Global Dental Periodontics market is segmented as follows:

By Deployment Mode

• On-Premise
• Cloud-based
• Web bases

By Model

• Knowledge-based
• Non-Knowledge based

By Product Type

• Standalone HDSS Solution
• Integrated HDSS Solution

By Offering

• Services
• Software
• Hardware

By Application

• Advanced CDSS
• Conventional CDSS

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com